Versor Investments’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-18,800
Closed -$171K – 944
2024
Q4
$171K Buy
+18,800
New +$182K 0.03% 698
2024
Q3
– Sell
-32,800
Closed -$321K – 974
2024
Q2
$321K Sell
32,800
-3,151
-9% -$38.4K 0.06% 493
2024
Q1
$543K Buy
+35,951
New +$652K 0.11% 304
2023
Q4
– Sell
-30,536
Closed -$568K – 857
2023
Q3
$568K Sell
30,536
-4,200
-12% -$98K 0.11% 255
2023
Q2
$880K Buy
+34,736
New +$874K 0.15% 103

Other funds holding TDOC

Versor Investments's TDOC Position: Q1 2025 in Review

Versor Investments sold out of Teladoc Health (TDOC) in Q1 2025, closing a stake of 18,800 shares — an estimated $171K sold.

Versor Investments first reported a position in TDOC in Q2 2023 and held it in 5 quarters. The position peaked at $880K in Q2 2023. 384 funds tracked by Wall St. Rank hold TDOC as of Q1 2025.

  • Versor Investments reported no remaining Teladoc Health position as of Q1 2025 after selling out during the quarter.
  • Versor Investments sold 18,800 Teladoc Health shares in Q1 2025, an estimated $171K.
  • Versor Investments first reported a position in Teladoc Health in Q2 2023 and held it in 5 quarters.
  • Versor Investments's Teladoc Health position peaked at $880K in Q2 2023.
  • 384 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2025.

Based on Versor Investments's 13F filing for Q1 2025, filed 13 May 2025.